Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Charles River Laboratories Intl (CRL)

Charles River Laboratories Intl (CRL)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 11,748,149
  • Shares Outstanding, K 50,805
  • Annual Sales, $ 3,540 M
  • Annual Income, $ 390,980 K
  • 60-Month Beta 1.27
  • Price/Sales 0.33
  • Price/Cash Flow 14.75
  • Price/Book 4.52
Trade CRL with:

Options Overview Details

View History
  • Implied Volatility 47.84% ( +3.61%)
  • Historical Volatility 54.62%
  • IV Percentile 91%
  • IV Rank 58.20%
  • IV High 64.59% on 04/28/22
  • IV Low 24.52% on 08/13/21
  • Put/Call Vol Ratio 1.43
  • Today's Volume 17
  • Volume Avg (30-Day) 182
  • Put/Call OI Ratio 0.60
  • Today's Open Interest 3,757
  • Open Int (30-Day) 8,507

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 10 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/22
See More
  • Average Estimate 2.83
  • Number of Estimates 6
  • High Estimate 2.89
  • Low Estimate 2.80
  • Prior Year 2.61
  • Growth Rate Est. (year over year) +8.43%

Price Performance

See More
Period Period Low Period High Performance
1-Month
217.20 +2.83%
on 05/12/22
265.00 -15.72%
on 05/04/22
-49.68 (-18.20%)
since 04/22/22
3-Month
217.20 +2.83%
on 05/12/22
308.15 -27.52%
on 04/08/22
-66.68 (-22.99%)
since 02/24/22
52-Week
217.20 +2.83%
on 05/12/22
460.21 -51.47%
on 09/24/21
-107.82 (-32.56%)
since 05/24/21

Most Recent Stories

More News
Here's Why You Should Retain Charles River (CRL) Stock for Now

Investors are optimistic about Charles River (CRL) due to the strong first-quarter results.

UNH : 497.56 (+1.11%)
ALKS : 28.35 (-3.24%)
CRL : 223.35 (-3.41%)
MEDP : 133.32 (-0.30%)
Charles River (CRL) DSA Arm Prospers, Currency Headwind Stays

Charles River (CRL) broadens the scope of the products and services across the drug discovery and early-stage development continuum through focused acquisitions.

UNH : 497.56 (+1.11%)
ALKS : 28.35 (-3.24%)
CRL : 223.35 (-3.41%)
MEDP : 133.32 (-0.30%)
Charles River (CRL) Q1 Earnings Top, Gross Margin Falls

Charles River (CRL) Q1 results highlight 9.8% organic revenue growth, driven by strength across all three segments.

UNH : 497.56 (+1.11%)
ALKS : 28.35 (-3.24%)
CRL : 223.35 (-3.41%)
MEDP : 133.32 (-0.30%)
Charles River Laboratories (CRL) Q1 Earnings and Revenues Beat Estimates

Charles River (CRL) delivered earnings and revenue surprises of 1.48% and 0.64%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

CRL : 223.35 (-3.41%)
SHC : 20.35 (+0.25%)
Charles River Laboratories Announces First-Quarter 2022 Results

Charles River Laboratories International, Inc. (NYSE: CRL) today reported its results for the first quarter of 2022. For the quarter, revenue was $913.9 million, an increase of 10.8% from $824.6 million...

CRL : 223.35 (-3.41%)
MedTech Stocks' Q1 Earnings Due on May 4: CRL, IDXX & NUVA

MedTech companies' results are likely to reflect a rebound in the base business. Let's see how CRL, IDXX and NUVA fare this time.

CRL : 223.35 (-3.41%)
IDXX : 362.16 (-1.68%)
NUVA : 55.16 (+0.95%)
Charles River (CRL) to Report Q1 Earnings: What's in Store?

Robust global demand for the research model and multiple initiatives to expedite the discovery process are likely to have contributed to Charles River's (CRL) first-quarter results.

VIVO : 25.97 (-0.04%)
ALC : 73.28 (-0.20%)
CRL : 223.35 (-3.41%)
CPSI : 31.29 (-1.91%)
Charles River and Valo Launch Logica, an Integrated AI-Powered Drug Discovery Solution to Rapidly Deliver Optimized Preclinical Assets

Charles River Laboratories International, Inc. (NYSE: CRL) and Valo Health, Inc (“Valo”) have launched Logica TM , an artificial intelligence (AI) powered drug solution that directly translates clients’...

CRL : 223.35 (-3.41%)
Stocks Recover Early Losses as T-note Yields and Inflation Expectations Fall

What you need to know… The S&P 500 Index ($SPX ) (SPY ) on Monday closed up +0.57%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.70%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up...

$SPX : 3,941.48 (-0.81%)
SPY : 393.89 (-0.76%)
$DOWI : 31,928.62 (+0.15%)
DIA : 319.39 (+0.17%)
$IUXX : 11,769.84 (-2.20%)
QQQ : 287.24 (-2.13%)
GOOGL : 2,119.40 (-4.95%)
MSFT : 259.62 (-0.40%)
QCOM : 128.53 (-2.72%)
PHM : 40.93 (-3.54%)
DHI : 65.63 (-2.68%)
LEN : 71.99 (-2.91%)
Stocks Slide as Chinese Covid Lockdowns Undercut Global Growth Prospects

What you need to know… The S&P 500 Index ($SPX ) (SPY ) this morning is down -1.15%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -1.14%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.30%....

$SPX : 3,941.48 (-0.81%)
SPY : 393.89 (-0.76%)
$DOWI : 31,928.62 (+0.15%)
DIA : 319.39 (+0.17%)
$IUXX : 11,769.84 (-2.20%)
QQQ : 287.24 (-2.13%)
SLB : 43.90 (+0.21%)
XOM : 94.40 (+0.54%)
HAL : 38.48 (+0.39%)
OXY : 65.07 (-0.54%)
COP : 109.48 (+0.42%)
FANG : 135.78 (-0.24%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Charles River Laboratories International, Inc. is a full service, early-stage contract research organization. The company provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions globally accelerate their research...

See More

Key Turning Points

3rd Resistance Point 239.06
2nd Resistance Point 235.03
1st Resistance Point 229.19
Last Price 223.35
1st Support Level 219.31
2nd Support Level 215.28
3rd Support Level 209.44

See More

52-Week High 460.21
Fibonacci 61.8% 367.38
Fibonacci 50% 338.70
Fibonacci 38.2% 310.03
Last Price 223.35
52-Week Low 217.20

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar